This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Tris Pharma, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovator Spotlight: Grishma Patel
Introduction
Grishma Patel, an inventive mind based in East Brunswick, NJ, has made significant contributions to the field of pharmaceuticals. With an impressive focus on developing innovative drug delivery systems, she has successfully secured a patent that showcases her expertise and commitment to enhancing patient care.
Latest Patents
Grishma Patel holds a notable patent for a "Liquid Clonidine Extended Release Composition." This oral dosage unit is designed to provide a 24-hour extended release profile following a single dose administration. The formulation comprises a pharmaceutically effective amount of a coated complex that features clonidine bound to a cationic exchange resin. This unique composition is characterized by its sustained release profile, enhancing its effectiveness in managing conditions that clonidine is used for. Additionally, the dosage units may incorporate an immediate release component, offering flexibility in treatment options.
Career Highlights
Grishma Patel is associated with Tris Pharma, Inc., an organization renowned for its innovative approaches in pharmaceutical development. Her role within the company has enabled her to contribute significantly to advanced drug formulations, employing her expertise to realize impactful health solutions for patients.
Collaborations
Throughout her career, Patel has engaged in collaborations that emphasize her commitment to innovation in the pharmaceutical space. By working alongside cross-functional teams at Tris Pharma, she has been able to merge scientific research with practical applications, paving the way for transformative therapeutic options.
Conclusion
Grishma Patel exemplifies the spirit of innovation and dedication within the pharmaceutical industry. Her patented work on liquid clonidine extended release composition not only reflects her technical prowess but also underscores the importance of developing accessible and effective treatment options. As she continues her journey at Tris Pharma, her contributions will undoubtedly leave a lasting impact on patients and the healthcare community alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile